KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication.
暂无分享,去创建一个
Alessandro Beghini | Enrica Morra | Andrea Biondi | Giovanni Cazzaniga | O. Haas | G. Nadali | R. Cairoli | E. Morra | A. Biondi | G. Cazzaniga | L. Larizza | Oskar A Haas | Lidia Larizza | A. Beghini | C. Ripamonti | F. Elice | Giovanni Grillo | G. Grillo | P. Colapietro | Roberto Cairoli | Carla B Ripamonti | Patrizia Colapietro | Francesca Elice | Gianpaolo Nadali | Andrea Biondi | Francesca Elice | Oskar A Haas | Enrica Morra | Lidia Larizza | E. Morra | Oskar A. Haas | A. Biondi
[1] I. Weissman,et al. AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Downing,et al. Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. , 2002, Cancer cell.
[3] J. Reilly. Class III receptor tyrosine kinases: role in leukaemogenesis , 2002, British journal of haematology.
[4] J. Downing. The core-binding factor leukemias: lessons learned from murine models. , 2003, Current opinion in genetics & development.
[5] M. Valsecchi,et al. FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia , 2003, British journal of haematology.
[6] L. Larizza,et al. Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia. , 2002, The hematology journal : the official journal of the European Haematology Association.
[7] L. Castilla,et al. Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11. , 2002, Blood.
[8] R. Cairoli,et al. C-Kit point mutations in core binding factor leukemias: correlation with white blood cell count and the white blood cell index , 2003, Leukemia.
[9] P. Peterlongo,et al. C-kit mutations in core binding factor leukemias. , 2000, Blood.
[10] J. Downing,et al. Characteristics and outcome of t(8;21)-positive childhood acute myeloid leukemia: a single institution's experience , 2002, Leukemia.
[11] F. v.,et al. Reply to SE Langabeer et al , 2003, Leukemia.
[12] M. Fukayama,et al. C‐kit Gene Abnormalities in Gastrointestinal Stromal Tumors (Tumors of Interstitial Cells of Cajal) , 1999, Japanese journal of cancer research : Gann.
[13] L. Ashman,et al. Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant. , 2002, Molecular cancer therapeutics.
[14] R. Cairoli,et al. Trisomy 4 leading to duplication of a mutated KIT allele in acute myeloid leukemia with mast cell involvement. , 2000, Cancer genetics and cytogenetics.
[15] J. Reilly,et al. Incidence and prognosis of c‐KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias , 2003, British journal of haematology.
[16] C. Mecucci,et al. Genetic profile of acute myeloid leukemia. , 2002, Reviews in clinical and experimental hematology.
[17] T. Kyo,et al. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML , 2003, Leukemia.
[18] D. Gilliland,et al. Core-binding factors in haematopoiesis and leukaemia , 2002, Nature Reviews Cancer.
[19] M. Caligiuri,et al. Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] S. Langabeer,et al. AML with t(8;21) and trisomy 4: possible involvement of c-kit? , 2003, Leukemia.
[21] T. Naoe,et al. Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia , 1997, Leukemia.
[22] J. Reilly,et al. c‐kit proto‐oncogene exon 8 in‐frame deletion plus insertion mutations in acute myeloid leukaemia , 1999, British journal of haematology.
[23] R. Arceci,et al. Activating Mutations of c-Kit at Codon 816 Confer Drug Resistance in Human Leukemia Cells , 2001, Leukemia & lymphoma.
[24] Lisa Garrett,et al. The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia , 1999, Nature Genetics.